Tuulonen Anja

A New SITA Perimetric Threshold Testing Algorithm: Construction and a Multicenter Clinical Study.

Mean (standard deviation) test times were 171.9 (45.3) seconds for SITA Faster, 247.0 (56.7) for SITA Fast, and 369.5 (64.5) for SITA Standard (P < .001).

False Positive Responses in Standard Automated Perimetry.

Across 3 different standard automated perimetry thresholding algorithms, FP rates showed only weak associations with visual field test results, except in severe glaucoma.

Right services to right patients at right time in right setting in Tays Eye Centre.

Revised operational concepts and new facilities together with a 15% increase in work contribution led to a 46% increase in overall productivity, improved access to care and the clearance of delayed services.

Prevalence of glaucoma in the Northern Finland Birth Cohort Eye Study.

The study provides up-to-date information on the prevalence of glaucoma in a middle-aged Caucasian population in Finland. The baseline data reported here allows the evaluation of the cost-effectiveness of screening later on.

Glaucoma blindness at the end of life.

The first ophthalmic Choosing Wisely recommendations in Finland for glaucoma and wet age-related macular degeneration.

Use of Ocular Hypotensive Medications in Portugal: PEM Study: A Cross-sectional Nationwide Analysis.

A significant percentage of the Portuguese population is currently treated with IOP-lowering medications, and the majority of them are on monotherapy.

A comprehensive model for measuring real-life cost-effectiveness in eyecare: automation in care and evaluation of system (aces-rwm™).

The core value and strength of the model lies in the consensus and collaboration of all Finnish university eye clinics to collect and evaluate the uniformly structured real-world outcomes data.

Glaucoma progression in patients receiving intravitreal anti-VEGF treatment for neovascular age-related macular degeneration.

nAMD and glaucoma were found co-existing in the same eye at rates that were similar to the age-corrected prevalence of the two diseases in the general population.

A prototype protocol for evaluating the real-world data set using a structured electronic health record in glaucoma.

The developed structured data presentation enables comparisons between different population-based real-world glaucoma data sets and glaucoma clinics.

Prototype master protocol for benchmarking of real-world follow-up data in glaucoma.

This study represents a first step toward the development of a master protocol for real-world benchmarking of glaucoma care.

The usefulness of routine photography in a myopic patient treated for glaucoma: 36-year follow-up.

Missed Opportunities in Screening for Glaucoma.

As resources will never be sufficient for all health care activities that providers wish to deliver and what people wish to receive, we need to ask big questions and adopt a public health perspective in glaucoma and eye care.

European Glaucoma Society research priorities for glaucoma care.

We have developed a list of priorities for glaucoma research involving clinicians and patients from different European countries that will help guide research efforts and investment.

European Glaucoma Society - A guide on surgical innovation for glaucoma.

This guide from the European Glaucoma Society offers crucial advice on surgical innovation for glaucoma, emphasizing rigorous evaluation and patient safety. It promotes responsible development and adoption of new surgical techniques to improve patient outcomes.

A Systematic Review of End-of-Life Visual Impairment in Open-Angle Glaucoma: An Epidemiological Autopsy.

CONCLUSIONS: Further prevention of blindness in glaucoma patients is needed.